Abstract
We describe the synthesis of sugar-fused β-disubstituted γ-butyrolactones, γ-butyrolactams and a lipophilic β-disubstituted GABA analogue as potential GABA receptor ligands, where the pharmacophore is engineered into the carbohydrate scaffold in the form of a C-fructoside. The products were characterized for receptor binding studies of GABA A receptors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have